Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) have invested £500K in significantly expanding their tablet manufacturing capabilities with the addition of tablet processing equipment for wet granulation, roller compaction, tablet compression, hardness testing, dedusting, weight sorting and tablet coating throughout 2019 and 2020. This investment of...
Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc., a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases....
Medilink EM Patron Spotlight: Morningside Pharmaceuticals
Medilink EM works with life science businesses, academic institutions and the NHS across the East Midlands, to help new and existing life science companies to develop and grow. In addition to the business support programmes it helps to deliver, Medilink EM provides a range of valuable benefits for its members,...
The impact of COVID-19 on innovation
Times of crisis are sometimes accompanied by huge spikes in innovation. Much like a fight-or-flight response in individuals, a knee-jerk reaction to adverse conditions for some organisations is to develop new technology as fast as possible. However, it very much depends on the nature of the adversity. The impact of...
The Medilink Big Ask
We have received a positive response to the Medilink Midlands Big Ask Questionnaire. This issue details the Key COVID-19 Asks along with a complete directory of company details, how to contact them, and what they can offer or need. Thank you to all those who have responded so far. Join the ‘Big Ask’...
Source BioScience develops COVID-19 testing capability
Source BioScience Limited, a highly accredited ISO:15189:2012 international laboratory services provider, has rapidly developed a robust COVID-19 testing capability to assist in the national effort to combat this deadly pandemic. Source leveraged its core scientific staff from its established clinical and healthcare diagnostics teams to develop its initial offering of...
The EU MDR deadline push-back: what exactly does this change?
The European Commission has delayed the date of application for the EU Medical Device Regulation (MDR) by a full year in light of the current pandemic. The new date of May 26, 2021, has now been approved. Beth Crandall, Managing Director, Global Solutions Delivery Leader at Medilink EM Member, Maetrics...
AI Digital are proud to help in the delivery of 100,000 Covid-19 tests per day
Lincolnshire-based AI Digital have been working with a testing lab in Milton Keynes, to help in the delivery of 100,000 COVID-19 tests per day. AI Digital was honoured to have been asked by UK Biocentre to provide the project management services for the setting up of a major COVID-19 testing...
eg technology Supports Health Enterprise East Innovation Voucher Competition
eg technology is partnering with Health Enterprise East by supporting its latest Innovation Voucher Competition. The Innovation Voucher is designed to support NHS staff to develop their ideas for new medical technologies and will give the winner access to eg technology’s team of talented and agile engineers. eg technology has 18...
Nottingham’s XenoGesis wins prestigious Queen’s Award for Enterprise in recognition of export growth
Nottingham-based leading independent DMPK provider, XenoGesis, has been awarded the prestigious Queen’s Award for Enterprise, International Trade, in recognition of its outstanding year-on-year export growth. XenoGesis is one of only three Nottinghamshire-based companies and 12 in the whole of the East Midlands to receive a Queen’s Award this year. Founded...
